ExeVir Bio

Tweet this page
<
2021
2022
2023
2024
>
Registration as it was on 21 Feb 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

10,000€ - 24,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.1 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    ExeVir Bio   (ExeVir)

    EU Transparency Register

    180203343227-11 First registered on 18 Jun 2021

    Goals / Remit

    ExeVir is a clinical-stage company developing novel antibody therapies that help patients ward off infectious diseases. Our focus is on protecting populations unable to benefit from vaccines, such as immunocompromised individuals. The versatile VHH platform enables both prevention and treatment of bacterial and viral threats.

    Main EU files targeted

    - EU Strategy on COVID-19 and infectious diseases Therapeutics
    - A Pharmaceutical Strategy for Europe
    - Horizon Europe

    Address

    Head Office
    Technologiepark-Zwijnaarde 94
    Ghent 9052
    BELGIUM
    EU Office
    Technologiepark-Zwijnaarde 94
    Ghent 9052
    BELGIUM

    Website

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    10%1

    Lobbyists (Full time equivalent)

    0.1

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    ExeVir has contracted EURALIA to advise us

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Flanders Bio
    MEDVIA

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    10,000€ - 24,999€

    Major contributions in closed year

    TypeNameAmount
    Grant Horizon Europe 8,626,000€

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    10,000€ - 24,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard